These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36281064)

  • 1. Clonazolam Intoxication Case Report: Danger of Designer Benzodiazepines.
    Moore C; Hammers J; Marshall P
    Am J Forensic Med Pathol; 2022 Dec; 43(4):372-375. PubMed ID: 36281064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-fatal intoxications involving the novel benzodiazepine clonazolam: case series from the Emerging Drugs Network of Australia - Victoria project.
    Syrjanen R; Greene SL; Castle JW; Di Rago M; Hodgson SE; Abouchedid R; Graudins A; Schumann JL
    Clin Toxicol (Phila); 2023 Apr; 61(4):290-293. PubMed ID: 36988452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonazolam a new designer benzodiazepine intoxication confirmed by blood concentration.
    Sommerfeld-Klatta K; Łukasik-Głębocka M; Teżyk A; Panieński P; Żaba C; Zielińska-Psuja B
    Forensic Sci Int; 2020 May; 310():110237. PubMed ID: 32172178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood concentrations of new designer benzodiazepines in forensic cases.
    Høiseth G; Tuv SS; Karinen R
    Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
    Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
    J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes.
    Meyer MR; Bergstrand MP; Helander A; Beck O
    Anal Bioanal Chem; 2016 May; 408(13):3571-91. PubMed ID: 27071765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases.
    Heide G; Høiseth G; Middelkoop G; Øiestad ÅML
    J Anal Toxicol; 2020 Dec; 44(8):905-914. PubMed ID: 32369173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
    Pettersson Bergstrand M; Richter LHJ; Maurer HH; Wagmann L; Meyer MR
    Drug Test Anal; 2019 Jan; 11(1):45-50. PubMed ID: 29996009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detoxification after use of new psychoactive substances purchased online].
    Frost J; Mikkelsen T; Andersen MN; Bjerke HA; Gundersen POM; Aamo TO
    Tidsskr Nor Laegeforen; 2024 Mar; 144(4):. PubMed ID: 38506014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis in the Context of Designer Benzodiazepine Misuse.
    Noe G; Shah K; Quattlebaum T; Munjal S
    Cureus; 2023 Dec; 15(12):e50741. PubMed ID: 38234935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected North Carolina counterfeit pill-involved deaths, 2020-2022.
    Friederich LW; Cox ME; Hyson BE; Bishop-Freeman SC
    J Anal Toxicol; 2024 May; 48(4):242-251. PubMed ID: 38676414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fake Xanax: Designer Emerging Benzodiazepine Epidemic Linked to Morbidity and Mortality a Narrative Review.
    Kaye AD; Tassin JP; Upshaw WC; Robichaux CM; Frolov MV; Dupaquier MM; Fox JE; Sterritt J; Mathew J; Shekoohi S; Kaye AM; Edinoff AN
    Neurol Ther; 2024 May; ():. PubMed ID: 38727766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's in fake 'Xanax'?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets.
    Blakey K; Thompson A; Matheson A; Griffiths A
    Drug Test Anal; 2022 Mar; 14(3):525-530. PubMed ID: 34170084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017.
    Carpenter JE; Murray BP; Dunkley C; Kazzi ZN; Gittinger MH
    Clin Toxicol (Phila); 2019 Apr; 57(4):282-286. PubMed ID: 30430874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer benzodiazepine rat pharmacokinetics: A comparison of alprazolam, flualprazolam and flubromazolam.
    Canfield JR; Kisor DF; Sprague JE
    Toxicol Appl Pharmacol; 2023 Apr; 465():116459. PubMed ID: 36907383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of the novel designer benzodiazepine 4'-chloro deschloroalprazolam with alprazolam analysis in toxicology and seized drug DUID casework.
    Reber JD; Rodgers C; Ayala JL; Miller J; Stout P; Lee D
    J Anal Toxicol; 2023 Nov; 47(8):680-684. PubMed ID: 37530763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report.
    Hauck TS; Rochon S; Bahra P; Selby P
    J Addict Med; 2022 Mar-Apr 01; 16(2):e137-e139. PubMed ID: 33900229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flubromazolam--A new life-threatening designer benzodiazepine.
    Łukasik-Głębocka M; Sommerfeld K; Teżyk A; Zielińska-Psuja B; Panieński P; Żaba C
    Clin Toxicol (Phila); 2016; 54(1):66-8. PubMed ID: 26585557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.
    Edinoff AN; Nix CA; Odisho AS; Babin CP; Derouen AG; Lutfallah SC; Cornett EM; Murnane KS; Kaye AM; Kaye AD
    Neurol Int; 2022 Aug; 14(3):648-663. PubMed ID: 35997362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.